{"id":958864,"date":"2026-05-06T08:11:10","date_gmt":"2026-05-06T12:11:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/"},"modified":"2026-05-06T08:11:10","modified_gmt":"2026-05-06T12:11:10","slug":"aktis-oncology-to-present-at-the-bofa-securities-health-care-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/","title":{"rendered":"Aktis Oncology to Present at the BofA Securities Health Care Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BOSTON, May  06, 2026  (GLOBE NEWSWIRE) &#8212; Aktis Oncology, Inc. (NASDAQ:AKTS) (the \u201cCompany\u201d), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today announced that Matthew Roden, Ph.D., President and Chief Executive Officer of Aktis Oncology, will present at the BofA Securities Health Care Conference in Las Vegas, Nevada. The presentation will take place on Wednesday, May 13, 2026, at 10:00 a.m. PT.<\/p>\n<p>A live webcast of the presentations may be accessed via the Investors section of the Aktis website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eV4ADS787RuOulDFYOdg0IafYX08tnPDH_8H-Awe1AhCpSIwVhGEd3xeK7aeoLp3arw1l9ElxVujHKdrGCQTblNIYWKNmfpHuVT70S0RLBatbPBaIT7TkVFncJyfdGvZ\" rel=\"nofollow\" target=\"_blank\">investors.aktisoncology.com<\/a>. An archived replay of the event will be available on the website for approximately 90 days following the conference.<\/p>\n<p>\n        <strong>About Aktis\u2019 miniprotein radioconjugate platform<\/strong><br \/>\n        <br \/>Aktis has developed a proprietary, isotope-agnostic miniprotein radioconjugate platform to selectively deliver the tumor-killing properties of radioisotopes to targeted tumors. Aktis\u2019 therapeutic miniprotein radioconjugates are designed to maximize anti-cancer activity through high tumor penetration coupled with internalization and retention in cancer cells, while rapidly clearing from normal organs and tissues. The Aktis platform further enables clinicians to visualize and verify target engagement with imaging isotopes prior to exposure to therapeutic radioisotopes. Leveraging this platform, Aktis is advancing a pipeline of next-generation targeted radiopharmaceuticals to address the unmet needs of patients across a broad spectrum of solid tumors.<\/p>\n<p>\n        <strong>About Aktis Oncology<\/strong><br \/>\n        <br \/>Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. Aktis\u2019 most advanced clinical-stage pipeline program, AKY-1189, is a miniprotein radioconjugate targeting Nectin-4, with multi-indication potential across multiple tumor types, including locally advanced or metastatic urothelial cancer, breast cancer, non-small cell lung cancer, colorectal cancer, cervical cancer, and head and neck cancer. Aktis\u2019 second clinical-stage pipeline program, AKY-2519, is a miniprotein radioconjugate targeting B7-H3 expressing tumors, including prostate, lung, colorectal, and other solid tumors. Aktis has a discovery collaboration with Eli Lilly and Company to leverage Aktis\u2019 miniprotein platform to develop novel radioconjugates outside of its proprietary pipeline. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vWY_1Mt9I6i91cRDQ9ZpDrMwtr3YUGv0gm68vu6U2-41iLn3e9WxK8Gh7FRRn0A8imZ2vxVx8pUFJYOy_ZA9NsjGZC5Dh5Gk3PCIlJiMl3s=\" rel=\"nofollow\" target=\"_blank\">www.aktisoncology.com<\/a>.<\/p>\n<p>\n        <strong>Media contact:<\/strong><br \/>\n        <br \/>Melone Communications, LLC<br \/>Liz Melone<br \/>617-256-6622<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=q7frnG934rstpRptsvdtshHjhATEHRRQmLZvnzI6dLAOkPfEGTKfg4pmTPqx4FkiSQYzDaUXDK4JnvjAyatxwy73msmMwgM9s1zNdqzrKjM=\" rel=\"nofollow\" target=\"_blank\">liz@melonecomm.com<\/a><\/p>\n<p>\n        <strong>Investor contact:<\/strong><br \/>\n        <br \/>Precision AQ<br \/>Alex Lobo<br \/>212-698-8802<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=I3Y1aTFCCTqlZVJlXR6auEmIoHEwtq6V7Grlav4XFVFYjMTJYF2xppmWau7K1Jj6ZRwABs8_jVC-VTXThT-i52Xwm3gaJnYqtfew9oIV9aKU4SJdSyP9NiZumAVt8hio\" rel=\"nofollow\" target=\"_blank\">Alex.lobo@precisionaq.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjcxOSM3NTgxNzY5IzIyOTUxOTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzliZWJlZjItMDdmMS00YmI4LTlmNjYtZjhhNDUxYmZmYzEwLTEzMDY3NDktMjAyNi0wNS0wNi1lbg==\/tiny\/Aktis-Oncology-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, May 06, 2026 (GLOBE NEWSWIRE) &#8212; Aktis Oncology, Inc. (NASDAQ:AKTS) (the \u201cCompany\u201d), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today announced that Matthew Roden, Ph.D., President and Chief Executive Officer of Aktis Oncology, will present at the BofA Securities Health Care Conference in Las Vegas, Nevada. The presentation will take place on Wednesday, May 13, 2026, at 10:00 a.m. PT. A live webcast of the presentations may be accessed via the Investors section of the Aktis website at investors.aktisoncology.com. An archived replay of the event will be available on the website for approximately 90 days following the conference. About Aktis\u2019 miniprotein radioconjugate &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aktis Oncology to Present at the BofA Securities Health Care Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-958864","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aktis Oncology to Present at the BofA Securities Health Care Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aktis Oncology to Present at the BofA Securities Health Care Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, May 06, 2026 (GLOBE NEWSWIRE) &#8212; Aktis Oncology, Inc. (NASDAQ:AKTS) (the \u201cCompany\u201d), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today announced that Matthew Roden, Ph.D., President and Chief Executive Officer of Aktis Oncology, will present at the BofA Securities Health Care Conference in Las Vegas, Nevada. The presentation will take place on Wednesday, May 13, 2026, at 10:00 a.m. PT. A live webcast of the presentations may be accessed via the Investors section of the Aktis website at investors.aktisoncology.com. An archived replay of the event will be available on the website for approximately 90 days following the conference. About Aktis\u2019 miniprotein radioconjugate &hellip; Continue reading &quot;Aktis Oncology to Present at the BofA Securities Health Care Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-06T12:11:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjcxOSM3NTgxNzY5IzIyOTUxOTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aktis Oncology to Present at the BofA Securities Health Care Conference\",\"datePublished\":\"2026-05-06T12:11:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\\\/\"},\"wordCount\":379,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjcxOSM3NTgxNzY5IzIyOTUxOTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\\\/\",\"name\":\"Aktis Oncology to Present at the BofA Securities Health Care Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjcxOSM3NTgxNzY5IzIyOTUxOTk=\",\"datePublished\":\"2026-05-06T12:11:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjcxOSM3NTgxNzY5IzIyOTUxOTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjcxOSM3NTgxNzY5IzIyOTUxOTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aktis Oncology to Present at the BofA Securities Health Care Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aktis Oncology to Present at the BofA Securities Health Care Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/","og_locale":"en_US","og_type":"article","og_title":"Aktis Oncology to Present at the BofA Securities Health Care Conference - Market Newsdesk","og_description":"BOSTON, May 06, 2026 (GLOBE NEWSWIRE) &#8212; Aktis Oncology, Inc. (NASDAQ:AKTS) (the \u201cCompany\u201d), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today announced that Matthew Roden, Ph.D., President and Chief Executive Officer of Aktis Oncology, will present at the BofA Securities Health Care Conference in Las Vegas, Nevada. The presentation will take place on Wednesday, May 13, 2026, at 10:00 a.m. PT. A live webcast of the presentations may be accessed via the Investors section of the Aktis website at investors.aktisoncology.com. An archived replay of the event will be available on the website for approximately 90 days following the conference. About Aktis\u2019 miniprotein radioconjugate &hellip; Continue reading \"Aktis Oncology to Present at the BofA Securities Health Care Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-06T12:11:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjcxOSM3NTgxNzY5IzIyOTUxOTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aktis Oncology to Present at the BofA Securities Health Care Conference","datePublished":"2026-05-06T12:11:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/"},"wordCount":379,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjcxOSM3NTgxNzY5IzIyOTUxOTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/","name":"Aktis Oncology to Present at the BofA Securities Health Care Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjcxOSM3NTgxNzY5IzIyOTUxOTk=","datePublished":"2026-05-06T12:11:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjcxOSM3NTgxNzY5IzIyOTUxOTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjcxOSM3NTgxNzY5IzIyOTUxOTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aktis-oncology-to-present-at-the-bofa-securities-health-care-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aktis Oncology to Present at the BofA Securities Health Care Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/958864","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=958864"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/958864\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=958864"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=958864"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=958864"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}